TickerFacts.

Altimmune, Inc. (ALT): Revenue

Annual figures by period end, from SEC filings.

$41.0K
Year ended 2025-12-31
$24.27M2010-12-31: $20.99M2011-12-31: $24.27M2021-12-31: $4.41M2022-12-31: -$68.0K2023-12-31: $426.0K2024-12-31: $20.0K2025-12-31: $41.0K$41.0K
2010-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$41.0K+105.0%2026-03-06, From 2025-01-01
2024-12-31$20.0K-95.3%2026-03-06, From 2024-01-01
2023-12-31$426.0Kn/m2025-02-27, From 2023-01-01
2022-12-31-$68.0Kn/m2024-03-27, From 2022-01-01
2021-12-31$4.41Mn/a2023-02-28, From 2021-01-01
No annual figure between 2011-12-31 and 2021-12-31.
2011-12-31$24.27M+15.6%2012-03-08, From 2011-01-01
2010-12-31$20.99Mn/a2012-03-08, From 2010-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Altimmune, Inc. (ALT)2025-12-31$41.0K+105.0%
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31$40.0K-51.8%
Lyell Immunopharma, Inc. (LYEL)2025-12-31$36.0K-41.0%
Lunai Bioworks Inc. (LNAI)2026-06-30$52.0Kn/a
Impact Biomedical Inc. (IBO)2025-12-31$32.0Kn/a
HCW Biologics Inc. (HCWB)2025-12-31$54.2K-97.9%
Avalo Therapeutics, Inc. (AVTX)2025-12-31$59.0K-86.6%
Talphera, Inc. (TLPH)2025-12-31$28.0Kn/a
Connect Biopharma Holdings Ltd (CNTB)2025-12-31$64.0K-99.8%

Compare ALT, NTHI, LYEL, LNAI side by side · Screen every company in Pharmaceutical Preparations ↗